Abstract
The rising incidence of breast cancer worldwide has prompted many improvements to current care. Routine nuclear medicine is a major contributor to a full gamut of clinical studies such as early lesion detection and stratification; guiding, monitoring, and predicting response to therapy; and monitoring progression, recurrence or metastases. Developments in instrumentation such as the high-resolution dedicated breast device coupled with the diagnostic versatility of conventional cameras have reinserted nuclear medicine as a valuable tool in the broader clinical setting. This review outlines the role of general nuclear medicine, concluding that targeted radiopharmaceuticals and versatile instrumentation position nuclear medicine as a powerful modality for patients with breast cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 54-65 |
| Number of pages | 12 |
| Journal | Journal of Medical Radiation Sciences |
| Volume | 62 |
| Issue number | 1 |
| Early online date | Feb 2015 |
| DOIs | |
| Publication status | Published - Mar 2015 |
